Market Overview:
Middle East precision medicine market size is projected to exhibit a growth rate (CAGR) of 6.96% during 2024-2032. The growing awareness about the potential of genomics, increasing prevalence of various chronic ailments like diabetes, arthritis, and cardiovascular complications, and rising integration of artificial intelligence (AI) and machine learning (ML) represent some of the key factors driving the market.
Report Attribute
|
Key Statistics
|
Base Year
|
2023 |
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Growth Rate (2024-2032) |
6.96% |
Precision medicine, also known as personalized medicine, customizes medical treatment to the individual characteristics of each patient. It involves the identification of biomarkers, which are specific biological indicators associated with certain diseases. It also includes immunotherapy, wherein treatments are tailored as per immune cell characteristics to enhance the ability of the body to fight diseases. It considers various factors, such as lifestyle and environmental influences, to design targeted interventions. It heavily relies on genomic sequencing to analyze the deoxyribonucleic acid (DNA) of an individual. It also provides insights into disease susceptibility and potential treatment responses. It conducts the integration of diverse data sources, including genetic, clinical, and environmental data, which is crucial for a holistic understanding of the health profile of an individual. It helps in enhancing the accuracy of antibiotic selection and treatment duration. It improves patient outcomes, leading to improved overall healthcare quality. It contributes to population health by identifying and addressing genetic susceptibilities. It can be implemented on a larger scale, reducing the burden of chronic diseases. It enables patients to actively participate in decision-making, fostering a sense of empowerment and engagement in their healthcare. Precision medicine contributes to the advancement of medical research by providing insights into the molecular basis of diseases.
Middle East Precision Medicine Market Trends:
At present, the increasing awareness about the potential of genomics and the role of genetic variations in diseases represents one of the crucial factors impelling the growth of the market in Middle East. Besides this, rising advancements in genomics and proteomics are enabling researchers and healthcare professionals to delve deeper into the molecular and genetic makeup of individuals. Next-generation sequencing (NGS) is also gaining traction as a cornerstone in deciphering the genetic code of an individual, offering valuable insights into disease susceptibility, progression, and treatment response. The integration of artificial intelligence (AI) and machine learning (ML) further enhances the analysis of complex biological data, facilitating more accurate diagnostics and treatment recommendations. In addition, as pharmaceutical companies are recognizing the importance of tailoring therapies according to the unique genetic profiles of individuals, the demand for companion diagnostics is growing in the region. This trend is also fostering collaborations between pharmaceutical and diagnostics companies, leading to the development of targeted therapies that are more effective and less prone to adverse effects. Apart from this, precision medicine offers a shift in the treatment of cancer by moving away from a one-size-fits-all approach to a more personalized and targeted strategy. The ability to identify specific genetic mutations or biomarkers associated with various types of cancers allows for the development of tailored therapies that are more effective in managing and treating the underlying causes. Additionally, the rising occurrence of various chronic ailments like diabetes, arthritis, and cardiovascular complications among the masses is supporting the market growth in the region. Moreover, governing agencies and healthcare organizations are promoting initiatives and policies that facilitate the integration of precision medicine into mainstream healthcare systems.
Middle East Precision Medicine Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the regional and country levels for 2024-2032. Our report has categorized the market based on product, technology, application, and end user.
Product Insights:
- Consumables
- Instruments
- Services
The report has provided a detailed breakup and analysis of the market based on the product. This includes consumables, instruments, and services.
Technology Insights:
- Big Data Analytics
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Companion Diagnostics
- Others
A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others.
Application Insights:
- Oncology
- Central Nervous System (CNS)
- Immunology
- Respiratory Medicine
- Infections
- Others
The report has provided a detailed breakup and analysis of the market based on the application. This includes oncology, central nervous system (CNS), immunology, respiratory medicine, infections, and others.
End User Insights:
- Hospitals and Clinics
- Diagnostic Centers
- Pharma and Biotech Companies
- Healthcare IT Firms
- Others
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and clinics, diagnostic centers, pharma and biotech companies, healthcare IT firms, and others.
Country Insights:
- Saudi Arabia
- Turkey
- Israel
- United Arab Emirates
- Iran
- Iraq
- Qatar
- Kuwait
- Oman
- Jordan
- Bahrain
- Others
The report has also provided a comprehensive analysis of all the major regional markets, which include Saudi Arabia, Turkey, Israel, United Arab Emirates, Iran, Iraq, Qatar, Kuwait, Oman, Jordan, Bahrain, and Others.
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Middle East Precision Medicine Market Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Million |
Scope of the Report |
Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
- Product
- Technology
- Application
- End User
- Country
|
Products Covered |
Consumables, Instruments, Services |
Technologies Covered |
Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Others |
Applications Covered |
Oncology, Central Nervous System (CNS), Immunology, Respiratory Medicine, Infections, Others |
End Users Covered |
Hospitals and Clinics, Diagnostic Centers, Pharma and Biotech Companies, Healthcare IT Firms, Others |
Countries Covered |
Saudi Arabia, Turkey, Israel, United Arab Emirates, Iran, Iraq, Qatar, Kuwait, Oman, Jordan, Bahrain, Others |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the Middle East precision medicine market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Middle East precision medicine market?
- What is the breakup of the Middle East precision medicine market on the basis of product?
- What is the breakup of the Middle East precision medicine market on the basis of technology?
- What is the breakup of the Middle East precision medicine market on the basis of application?
- What is the breakup of the Middle East precision medicine market on the basis of end user?
- What are the various stages in the value chain of the Middle East precision medicine market?
- What are the key driving factors and challenges in the Middle East precision medicine?
- What is the structure of the Middle East precision medicine market and who are the key players?
- What is the degree of competition in the Middle East precision medicine market?
Key Benefits for Stakeholders:
- IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Middle East precision medicine market from 2018-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the Middle East precision medicine market.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Middle East precision medicine industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.